SE7501115L - Forfarande for framstellning av tyrosinderivat med farmaceutisk aktivitet pa glatt muskulatur. - Google Patents
Forfarande for framstellning av tyrosinderivat med farmaceutisk aktivitet pa glatt muskulatur.Info
- Publication number
- SE7501115L SE7501115L SE7501115A SE7501115A SE7501115L SE 7501115 L SE7501115 L SE 7501115L SE 7501115 A SE7501115 A SE 7501115A SE 7501115 A SE7501115 A SE 7501115A SE 7501115 L SE7501115 L SE 7501115L
- Authority
- SE
- Sweden
- Prior art keywords
- tyrosin
- derivatives
- procedure
- preparation
- pharmaceutical activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT67286/74A IT1062206B (it) | 1974-02-01 | 1974-02-01 | Derivati della tirosina attivi sulla muscolatura liscia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7501115L true SE7501115L (sv) | 1975-08-04 |
| SE413094B SE413094B (sv) | 1980-04-14 |
Family
ID=11301149
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7501115A SE413094B (sv) | 1974-02-01 | 1975-01-31 | Analogiforfarande for framstellning av tyrosinderivat med farmaceutisk aktivitet pa glatt muskulatur |
| SE7501114A SE410850B (sv) | 1974-02-01 | 1975-01-31 | Forfarande for framstellning av d,l-tyrosinderivat med farmacentisk aktivitet pa glatt muskulatur |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7501114A SE410850B (sv) | 1974-02-01 | 1975-01-31 | Forfarande for framstellning av d,l-tyrosinderivat med farmacentisk aktivitet pa glatt muskulatur |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4004008A (sv) |
| JP (2) | JPS5417728B2 (sv) |
| AT (2) | AT343632B (sv) |
| BE (1) | BE824995A (sv) |
| CA (2) | CA1047498A (sv) |
| CH (2) | CH605658A5 (sv) |
| DE (1) | DE2503992C2 (sv) |
| ES (1) | ES434323A1 (sv) |
| FI (2) | FI63744C (sv) |
| FR (1) | FR2259592B1 (sv) |
| GB (1) | GB1467927A (sv) |
| HK (1) | HK38979A (sv) |
| HU (2) | HU175156B (sv) |
| IN (1) | IN139364B (sv) |
| IT (1) | IT1062206B (sv) |
| NL (1) | NL167683C (sv) |
| NO (2) | NO144211C (sv) |
| SE (2) | SE413094B (sv) |
| ZA (1) | ZA75530B (sv) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5225243A (en) * | 1975-08-20 | 1977-02-25 | Toshiba Electric Equip Corp | Distributing panel |
| US4579866A (en) * | 1984-05-29 | 1986-04-01 | Usv Pharmaceutical Corp. | Phenylacetamides as anti-allergy, anti-asthma and anti-inflammatory agents |
| US5198458A (en) * | 1986-02-04 | 1993-03-30 | Suntory Limited | Pyrrolidineamide derivatives of acylamino acid and pharmaceutical composition containing the same |
| CA1320734C (en) * | 1986-02-04 | 1993-07-27 | Suntory Limited | Pyrrolidineamide derivative of acylamino acid and pharmaceutical composition containing the same |
| IL99537A (en) * | 1990-09-27 | 1995-11-27 | Merck & Co Inc | Fibrinogen receptor antagonists and pharmaceutical preparations containing them |
| NZ239846A (en) * | 1990-09-27 | 1994-11-25 | Merck & Co Inc | Sulphonamide derivatives and pharmaceutical compositions thereof |
| US5258407A (en) * | 1991-12-31 | 1993-11-02 | Sterling Winthrop Inc. | 3,4-disubstituted phenols-immunomodulating agents |
| US5206373A (en) * | 1992-02-28 | 1993-04-27 | Merck & Co., Inc. | Process for preparing fibrinogen receptor antagonists |
| DE10204951A1 (de) * | 2002-02-06 | 2003-08-14 | Basf Ag | Phenylalaninderivate als Herbizide |
| CN1894202A (zh) * | 2003-12-19 | 2007-01-10 | 巴斯福股份公司 | 苯甲酰基取代的苯基丙氨酸酰胺 |
| AU2006270914B2 (en) * | 2005-07-19 | 2011-01-20 | Daiichi Sankyo Company, Limited | Substituted propanamide derivative and pharmaceutical composition containing the same |
| WO2011094890A1 (en) * | 2010-02-02 | 2011-08-11 | Argusina Inc. | Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators |
| EP2579888A2 (en) | 2010-06-09 | 2013-04-17 | Receptos, Inc. | Novel glp-1 receptor stabilizers and modulators |
| WO2012166951A1 (en) | 2011-05-31 | 2012-12-06 | Receptos, Inc. | Novel glp-1 receptor stabilizers and modulators |
| RU2634896C2 (ru) | 2011-12-12 | 2017-11-08 | Селджин Интернэшнл Ii Сарл | Новые модуляторы рецептора glp-1 |
| CN102659619A (zh) * | 2012-04-18 | 2012-09-12 | 上海骏捷生化科技有限公司 | 一种合成酪氨酸衍生物的方法 |
| CN103508921B (zh) * | 2012-06-21 | 2015-09-30 | 贵州百灵企业集团制药股份有限公司 | 一种苯丙氨醇化合物的制备方法 |
| CN103508920B (zh) * | 2012-06-21 | 2016-03-02 | 贵州百灵企业集团制药股份有限公司 | 一种苯丙氨醇化合物的光学异构体的制备方法及其用途 |
| EP3008056B8 (en) | 2013-06-11 | 2021-03-03 | Receptos Llc | Novel glp-1 receptor modulators |
| MX2017000972A (es) | 2014-07-25 | 2017-07-27 | Celgene Int Ii Sarl | Nuevos moduladores del receptor de peptido similar a glucagon 1 (glp-1). |
| JP2017538711A (ja) | 2014-12-10 | 2017-12-28 | セルジーン インターナショナル ツー エスエーアールエル | Ｇｌｐ−１レセプターモジュレーター |
| CN107417560B (zh) * | 2017-03-30 | 2020-05-22 | 上海常丰生物医药科技有限公司 | 一种合成盐酸替罗酰胺的方法 |
| CN110015978B (zh) * | 2019-04-29 | 2021-03-19 | 康化（上海）新药研发有限公司 | O-[2-[[叔丁氧羰基]氨基]乙基]-n-[芴甲氧羰基]-l-酪氨酸的合成方法 |
| CN115850107A (zh) * | 2022-11-30 | 2023-03-28 | 苏州诚和医药化学有限公司 | 一种工业化合成盐酸替罗酰胺的方法 |
-
1974
- 1974-02-01 IT IT67286/74A patent/IT1062206B/it active Protection Beyond IP Right Term
-
1975
- 1975-01-22 GB GB287875A patent/GB1467927A/en not_active Expired
- 1975-01-24 ZA ZA00750530A patent/ZA75530B/xx unknown
- 1975-01-29 IN IN179/CAL/75A patent/IN139364B/en unknown
- 1975-01-30 CH CH110975A patent/CH605658A5/xx not_active IP Right Cessation
- 1975-01-30 NO NO750288A patent/NO144211C/no unknown
- 1975-01-30 FI FI750256A patent/FI63744C/fi not_active IP Right Cessation
- 1975-01-30 FI FI750255A patent/FI61479C/fi not_active IP Right Cessation
- 1975-01-30 CA CA219,027A patent/CA1047498A/en not_active Expired
- 1975-01-30 CA CA75219028A patent/CA1048503A/en not_active Expired
- 1975-01-30 NO NO750287A patent/NO144210C/no unknown
- 1975-01-30 BE BE152889A patent/BE824995A/xx not_active IP Right Cessation
- 1975-01-30 CH CH110875A patent/CH605657A5/xx not_active IP Right Cessation
- 1975-01-31 AT AT74675A patent/AT343632B/de not_active IP Right Cessation
- 1975-01-31 ES ES434323A patent/ES434323A1/es not_active Expired
- 1975-01-31 SE SE7501115A patent/SE413094B/sv unknown
- 1975-01-31 FR FR7503079A patent/FR2259592B1/fr not_active Expired
- 1975-01-31 AT AT74575A patent/AT342026B/de not_active IP Right Cessation
- 1975-01-31 JP JP1326675A patent/JPS5417728B2/ja not_active Expired
- 1975-01-31 NL NL7501193A patent/NL167683C/xx not_active IP Right Cessation
- 1975-01-31 JP JP1328575A patent/JPS5417729B2/ja not_active Expired
- 1975-01-31 HU HU75RO821A patent/HU175156B/hu unknown
- 1975-01-31 DE DE2503992A patent/DE2503992C2/de not_active Expired
- 1975-01-31 SE SE7501114A patent/SE410850B/sv not_active IP Right Cessation
- 1975-01-31 HU HU75RO820A patent/HU174825B/hu unknown
- 1975-02-03 US US05/546,481 patent/US4004008A/en not_active Expired - Lifetime
-
1979
- 1979-06-14 HK HK389/79A patent/HK38979A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE7501115L (sv) | Forfarande for framstellning av tyrosinderivat med farmaceutisk aktivitet pa glatt muskulatur. | |
| NO145199C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive nortropinestere. | |
| NO143219C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
| SE7505040L (sv) | Forfarande for framstellning av n-fosfonometylglycin. | |
| NO145382C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-amino-indazolkarboksylsyrederivater. | |
| NO143460C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner. | |
| NO140859C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive n-(metoksymetyl-furylmetyl)-6,7-benzomorfaner og -morfinaner | |
| SE7601204L (sv) | Terapeutiskt system for administrering av skopolamin transdermalt | |
| NO145056C (no) | (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater | |
| SE423544B (sv) | Analogiforfarande for framstellning av imidazolderivat med antifungisk aktivitet | |
| NO141850C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater. | |
| SE7504842L (sv) | Forfarande for framstellning av adeninderivat.. | |
| NO144928C (no) | Analogifremgangsmaate for fremstilling av fysiologisk aktive zantinderivater. | |
| SE397087B (sv) | Forfarande for framstellning av substituerade pgf-prostaglandinforeningar med lekemedelsverkan | |
| SE399557B (sv) | Forfarande for framstellning av tiantren-, tioxanten- och fenoxatiinderivat | |
| NO140104C (no) | Analogifremgangsmaate til fremstilling av 17beta-hydroksy-16,16-dimetylestr-4-en-3-on med terapeutisk aktivitet | |
| NO142403C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive isokinoliner. | |
| SE407687B (sv) | Forfarande for framstellnig av farmaceutiskt aktiva leurosinderivat | |
| NO139684C (no) | Fremgangsmaate for fremstilling av n,n-diallyldikloracetamid | |
| NL7610260A (nl) | Werkwijze ter bereiding van bij orale of anale toediening werkzame geneesmiddelen. | |
| SE7504507L (sv) | Forfarande for framstellning av 5-nitroimidazolderivat. | |
| TR17624A (tr) | 1-alkilidenaminourasiller,bunlarin hazirlanmasina mahsus usul ve bunlarin herbisid olarak kullanilmasi | |
| NL7415518A (nl) | Gesubstitueerde (alpha)-aminooxyhydroxaamzuur deriva- ten en werkwijzen voor hun bereiding en toepas- sing. | |
| NO142349C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 13-alkyl d-homogonadiener | |
| NO149427C (no) | Fremgangsmaate for fremstilling av fenyl- henholdsvis naftyl-uretaner. |